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Racemase and Hydroxyproline-2-Epimerase from
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Laboratoire d’Immunobiologie des Infections a ` Trypanosoma, De ´partement d’Immunologie, Institut Pasteur, Paris, France
The first eukaryotic proline racemase (PRAC), isolated from the human Trypanosoma cruzi pathogen, is a validated therapeutic
target against Chagas’ disease. This essential enzyme is implicated in parasite life cycle and infectivity and its ability to trigger
host B-cell nonspecific hypergammaglobulinemia contributes to parasite evasion and persistence. Using previously identified
PRAC signatures and data mining we present the identification and characterization of a novel PRAC and five hydroxyproline
epimerases (HyPRE) from pathogenic bacteria. Single-mutation of key HyPRE catalytic cysteine abrogates enzymatic activity
supporting the presence of two reaction centers per homodimer. Furthermore, evidences are provided that Brucella abortus
PrpA [for ‘proline racemase’ virulence factor A] and homologous proteins from two Brucella spp are bona fide HyPREs and not
‘one way’ directional PRACs as described elsewhere. Although the mechanisms of aminoacid racemization and epimerization
are conserved between PRAC and HyPRE, our studies demonstrate that substrate accessibility and specificity partly rely on
contraints imposed by aromatic or aliphatic residues distinctively belonging to the catalytic pockets. Analysis of PRAC and
HyPRE sequences along with reaction center structural data disclose additional valuable elements for in silico discrimination of
the enzymes. Furthermore, similarly to PRAC, the lymphocyte mitogenicity displayed by HyPREs is discussed in the context of
bacterial metabolism and pathogenesis. Considering tissue specificity and tropism of infectious pathogens, it would not be
surprising if upon infection PRAC and HyPRE play important roles in the regulation of the intracellular and extracellular amino
acid pool profiting the microrganism with precursors and enzymatic pathways of the host.
Citation: Goytia M, Chamond N, Cosson A, Coatnoan N, Hermant D, et al (2007) Molecular and Structural Discrimination of Proline Racemase and
Hydroxyproline-2-Epimerase from Nosocomial and Bacterial Pathogens. PLoS ONE 2(9): e885. doi:10.1371/journal.pone.0000885
INTRODUCTION
In recent years, an increasing interest rose concerning Proline
Racemases (PRAC). Originally isolated in 1957 from Clostridium
sticklandii (CsPRAC) [1], PRAC has been extensively studied in the
eighties by several groups at the biochemical level [2,3]. Lately, the
first eukaryotic PRAC was isolated from the Trypanosoma cruzi
pathogen (TcPRAC) and shown to be involved in the mechanisms
of parasite escape from host immune responses for its mitogenic
properties toward B lymphocytes [4,5]. TcPRAC is present in all
T. cruzi life cycle stages, is essential for parasite viability and it
appears to be involved in certain metabolic pathways during
metacyclogenesis as parasites overexpressing TcPRAC genes gain
better host infectivity [6]. Similar genes in the human genome lack
crucial enzyme catalytic residues thus consolidating TcPRAC as
a lead for drug development against trypanosomiasis [7,8].
Racemasescatalyzethedeprotonation/reprotonationofthechiral
carbon (C
a) of both amino acid enantiomers resulting in steroinver-
sion of chiral centers in reactions depending or not on pyridoxal
phosphate (PLP) cofactor. PRAC is a member of the PLP-
independent enzyme family along with Glutamate and Aspartate
Racemases and Diaminopimelate Epimerase [9]. Thermodynamic
studies and the overall 3D-structure of homodimeric TcPRAC in
complex with its competitive inhibitor provided evidences that
proline (Pro) racemization operates by stabilization of carbanionic
transition-state species in a two-Cystein-dependent acid/base
catalytic mechanism [10]. As demonstrated by site-specific muta-
genesis, racemization of Pro involves two catalytic cystein (Cys)
residues (Cys130 and Cys300 )p e rTcPRAC subunit.
Multiple alignment of functional PRAC amino acid sequences
and the analysis of the conserved Cys has enabled the definition of
minimal essential motifs (DRSPCGXGXXAXXA, i.e. MIII*, and
MCGH) [8] to identify putative PRACs. We investigated PRAC
homologous genes from pathogens by screening released genoma
databases to further explore novel potential therapeutic targets.
When MIII* signature was used for mining, 111 hits were
obtained, 92 of them possessing both catalytic residues.
The presence of functional PRAC was investigated in a collection
of 9 bacterial species of pathogenic importance (i.e. Firmicute, a-, b-
and c-proteobacteria) using molecular and biochemical approaches.
Current work unveils a new functional PRAC isolated from
Clostridium difficile and 5 novel functional Hydroxyproline-2-
Epimerases (HyPRE) specifically from Pseudomonas aeruginosa, Bur-
kholderia pseudomalleiand 3 Brucellaspecies. The studies alsoreveal that
MIII*, considered to be a minimal pattern to identify putative
PRAC, is not sufficiently stringent to discriminate PRAC from
HyPRE. Additional element motifs are provided for the discrimi-
nation of PRAC and HyPRE sequences based for instance on
polarity constraints imposed by precise residues of the catalytic
pockets that contribute to ligand specificity.
HyPRE, a PLP-independent enzyme described in the late
1950’s [11,12], presents overall sequence similarities with PRAC
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a of 4-hydroxyproline (OH-Pro).
Enzymatic activities of bacterial PRAC and HyPREs identified
here were fully characterized and specific Vmax and Km determined.
Furthermore, the data discloses that HyPRE enzymatic activity
equally depends on two catalytic Cys residues, as shown by single
mutation of Cys88 or Cys236 residues of P. aeruginosa HyPRE which
drastically impairs OH-Pro epimerization. This is the first work
associating simultaneously full-length HyPRE genes and functional
enzymatic activity of the encoded proteins.
The present data challenges recently published studies [13] and
establishes that a Brucella abortus virulence factor (PrpA), described
as PRAC, as well as homologous proteins from B. melitensis and B.
suis, are bona fide PLP-independent HyPREs that interconvert trans
or cis OH-L-Pro into cis or trans OH-D-Pro respectively and no
other amino acids.
Both Pro and OH-Pro are important compounds for growth
and development of many organisms. They can be used as
exclusive sources of carbon, nitrogen and energy and are the
principal components of collagen-the most widespread molecule in
higher organisms [14,15]. Moreover, the importance of PRAC
and HyPRE in the context of disease processes induced by
pathogenic microorganisms is discussed.
RESULTS
In silico gene selection of homologous PRAC genes
Blast searches of NCBI and Swiss-Prot/TrEMBL databases with
full-length TcPRAC sequences resulted in 184 hits from which 111
possess the minimal PRAC stringent MIII* among which 62 hits
were directly annotated as ‘PRAC’, without previous validation of
the enzymatic activity. The present analysis revealed that MIII*
and MCGH motif [10], encompassing the TcPRAC Cys300 and
Cys130 crucial residues respectively, were consistently present in 92
sequences. We formerly suggested that predicted proteins
originated from genes lacking these key Cys residues would
display functions other than Pro racemization [8]. A collection of
15 sequences was selected for further studies accordingly to
sequence identities with TcPRAC, to the conservation or not of
homologous Cys130 and Cys300 and the recognized pathogenic
importance of the microbial genomes.
As summarized in Table 1, homologous genes from different
pathogen strains, annotated as ‘putative PRAC’, ‘PRAC’ or
‘unknown’ proteins, display 29 to 56% homology with TcPRAC,
present either a conservation of the couple of catalytic Cys or
replacements of one or both Cys positions by serine (Ser) and/or
threonine (Thr) residues. A comparison between Brucella spp
sequences and the previously characterized TcPRAC and
CsPRAC was of note. Therefore, from the two available
homologous sequences for each Brucella specie only one meets
the requirements for PRAC activity and presents both key Cys
residues, the other presenting Ser and Thr substitutions.
Functional PRAC and Hydroxyproline epimerases of
pathogenic bacteria
The function of 12 gene products and their ability to interconvert
Pro residues was addressed. Purified recombinant proteins were
analyzed in biochemical assays by measuring the shift in optical
rotation of either L- or D-Pro. As shown in Figure 1, C. difficile (Cd)
recombinant protein racemized both L- and D-Pro but not OH-L/
D-Pro or any other natural amino acid. CdPRAC activity is PLP-
independent which closely resembles TcPRAC and CsPRAC [5,16].
Conversely, B. pseudomallei and P. aeruginosa recombinant proteins
presented no measurable PRAC activity but demonstrated strong
epimerization of OH-L/D-Pro behaving as genuine OH-Pro
epimerases. However, as predicted, control recombinant proteins
produced from B. cenocepacia and P. aeruginosa sequences that present
‘Cys-Thr’ or ‘Ser-Cys’ couple replacements respectively did not
show neither PRAC norHyPRE enzymaticactivities.Unexpectedly,
three tested recombinant proteins, two produced from Bacillus
anthracis and one from Vibrio parahaemolyticus, annotated as ‘putative
PRACs’andpresentingthe‘Cys-Cys’couplegeneratedrecombinant
proteins that did not display PRAC or HyPRE activities.
Brucella abortus PrpA virulence factor is a validated
hydroxyproline epimerase
One of the B. abortus sequences, presenting the ‘Cys-Cys’ couple,
was reported elsewhere as a B-cell mitogen with PRAC activity
(BaPrpA, for proline racemase protein A) and was shown to be
directly involved in bacterial virulence and immune system evasion
[13]. Surprisingly, PrpA would not be able to perform reversible
conversion of L- and D-Pro but only a L-Pro to D-Pro unidirectional
conversion. If correct, this assertion would imply that other PRAC
could behave likewise. The enzymatic activity of BaPrpA produced
from sequence 1 obtained in silico was then investigated. BaSeq1,
derived from Ba-strain 544, is 100% homologous to Ba-strain 9-941
and BaPrpA (Ba strain 2308, BAB1_1800) and possesses all PRAC
motifs (Figure S1). The present data undoubtedly demonstrate that
BaSeq1 displayed only HyPRE activity irrespective of the enzyme
concentration, pH and buffer conditions (Figures 2A and 2B), in
contrast to recurrent Pro racemization values obtained with
TcPRAC. Since BaSeq1 sequence is 98% homologous to proteins
annotated as ‘PRAC’ from B. melitensis (Bm) and B. suis (Bs) all three
recombinant homologous proteins were tested in parallel for PRAC
and HyPRE activities. These proteins were unable to catalyze Pro
racemization but exhibited equivalent strong ability to perform
epimerization of both OH-L-Pro and OH-D-Pro (Figure 2 C and
2D).Consequently,thedataprovesthatBaSeq1,andthereforePrpA,
is a HyPRE, as do B. melitensis and B. suis corresponding proteins.
Kinetic properties of bacterial hydroxyproline
epimerases
Optimum conditions for PRAC and HyPRE reactions for all
bacterial enzymes were obtained in NaOAc, pH 6 and Tris/
EDTA (TE), pH 8–9 buffers, respectively. On the other hand,
when PRAC was radically inhibited by its specific competitive
inhibitor pyrrole-2-carboxylic acid (PYC), no inhibition of HyPRE
was observed with standard amounts of PYC (1 mM) (Figures 3A
and 3B). HyPRE reactions were only affected by high amounts of
PYC (10 mM) or by variable concentrations of iodoacetate and
iodoacetamide inhibitors (Figure S2). Progress of Pro and OH-Pro
catalysis was monitored polarimetrically. The interconversion of
L,.D-Pro mediated by CdPRAC reveals that the enzyme has
comparable velocity and affinity constants to those of TcPRAC
(Figure 4). Graphic representation of the Michaelis-Menten equation
corresponding to the initial velocity of CdPRAC and PaHyPRE as
function of substrate concentration is shown, as well as respective Km
and Vmax kinetic values (Figure 4A and 4B). Brucella spp and B.
peudomallei HyPREs exhibited comparable Vmax and apparent Km
values to those of PaHyPRE(Figure4C).However,atequilibrium,all
HyPRE enzymes showed a clear advantage to OH-D-Pro substrate.
Additional elements to previously defined PRAC
signature can discriminate proline racemases and
hydroxyproline epimerases
Following blast searches using full-length TcPRAC sequence,
MIII* and MCGH block, we demonstrated that a number of
PRAC and HyPRE Enzymes
PLoS ONE | www.plosone.org 2 September 2007 | Issue 9 | e885Table 1. Database collection from in silico searches and complementary information on selected sequences.
..................................................................................................................................................
Pathogen Disease Acces. nb
{ MCGH
1 MIII*
1 TcPRAC Homology (%) Annot.
{
Trypanosoma cruzi CL Brener Chagas’ disease Q868H8 C C 100 PRAC
Bacillus anthracis Ames Anthrax Q81PH1 C C 40 Put. PRAC
Q81UH1 C C 40
Brucella abortus 9-941 Brucellosis Q57B94 (1) C C 40 Put. PRAC
Q57F22 (2) S T 29
Brucella melitensis 16M Brucellosis Q8YJ29 C C 40 PRAC
Q8YFD6 S T 29
Brucella suis 1330 Brucellosis Q8FYS0 C C 40 Put. PRAC
Q8G2I3 S T 29
Burkholderia cenocepacia HI2424 Pneumonia, sepsis A0AZQ0 C C 29 PRAC
A0B0B8 C T 37
Burkholderia pseudomallei K96243 Melioidosis Q63NG7 C C 34 Hyp. prot
Clostridium difficile 630 Nosocomial diarrhoea Q17ZY4 C C 56 Put. PRAC
Pseudomonas aeruginosa PAO1 Pneumonia, sepsis Q9I476 C C 33 Hyp. prot
Q9I489 S C 30
Vibrio parahaemolyticus O3 :K6 Diarrhoea Q87Q20 C C 37 PRAC
Sequences were obtained by blasting TcPRAC (Q868H8) against Swiss-Prot/TrEMBL or NCBI databases.
{Swiss-Prot accession number;
1MCGH and MIII
*motifs are minimal peptide sequences encompassing TcPRAC catalytic Cys (Cys130 and Cys300) residues;
{Related annotation from blast searches.
doi:10.1371/journal.pone.0000885.t001
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Figure 1. Enzymatic activities of PRAC and HyPRE from different
pathogens. Optimal reaction conditions consisted of 10 mg of the
enzyme and 20 mM of substrate in specific buffers during 30 min at
37uC. (A) Percent of L- or D-Pro racemization in NaOAc, pH 6; (B) Percent
of OH-L-Pro or OH-D-Pro epimerization in TE, pH 8. P. aeruginosa (SC)
and B. cenocepacia (CT) recombinant proteins whose sequences lack
one of the two Cys catalytic residues do not display any PRAC or HyPRE
activities.
doi:10.1371/journal.pone.0000885.g001
Figure 2. PrpA of B. abortus (BaSeq1) is an hydroxyproline-2-
epimerase. Reactions were performed with 3–10 mg of the enzyme and
40 mM of substrate in specific buffers during 1 h at 37uC. (A) Pro
racemization reactions were performed in NaOAc, pH 6. (B) OH-Pro
epimerization reactions were set up in parallel in TE, pH 9. Data from
Spera et al [13] was transposed to the Figure under shade and TcPRAC
was used as control; BaPrpA : purported ‘proline racemase protein A’;
BaSeq1 was produced from PrpA-corresponding sequence 1 from B.
abortus(Table1andFigureS1).PercentofL-orD-Proracemization(C)and
percent of OH-L-Pro or OH-D-Pro epimerization (D) using specific buffers,
10 mg of the enzyme and 20 mM of substrate during 30 min at 37uC.
doi:10.1371/journal.pone.0000885.g002
PRAC and HyPRE Enzymes
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enzyme. Sequences of PRAC and HyPRE were aligned and
residues that may be useful for their discrimination were identified
(Figure 5). Thus, although both enzymes possess the catalytic ‘Cys-
Cys’ couple, three major and non dissociated differences seem to
be noteworthy for substrate specificity. The first and most
important particularity is an aromatic phenylalanine (Phe) residue
which was shown to be capital to hydrophobic contacts of
TcPRAC with Pro ring carbon atoms that is missing in HyPRE
(depicted in R1). In fact, Phe imposes polarity constraints
precluding polar functions at the level of the substrate carbon
ring. Instead, HyPRE holds Ser or valine (Val) substitutions, i.e.
small polar or aliphatic amino acids, that would account for better
OH-Pro accessibility into the pocket. Other sequences encoding
proteins without enzymatic activity may present at that position,
polar tyrosine (Tyr) or histidine (His) residues which would restrict
PRAC or HyPRE catalysis, as observed with B. anthracis sequences.
Another feature is the presence in the TcPRAC pocket
environment of a Cys (or a Leucine, i.e. Leu, for other PRAC)
residue in position 270 while HyPREs possess in that position
a consistent polar His residue (depicted in R2) optimally placed to
favor H-bonding interaction with the OH- of the C
c-atom of OH-
Pro. Moreover, an additional block of three residues downstream
of the highly conserved MIII* (XLA, depicted in R3) is fully
restrictive to discriminate HyPRE and PRAC enzymes. These
three differences are complementary to the presence of the
‘Cys-Cys’ couple of the catalytic pockets as ascertained by the
absence of both enzymatic activities exhibited by B. anthracis and V.
parahaemolyticus proteins.
Abrogation of HyPRE enzymatic activity by mutation
of conserved cysteine residues of the catalytic site
HyPRE homodimer was described as having both subunits
participating in a single catalytic site [17,18]. The potential role
of ‘Cys-Cys’ couple in HyPRE catalysis was verified through site-
directed mutagenesis of PaHyPRE Cys88 or Cys236 into Ser
residues (Figure S3 and Table S1). In comparison to wild type
Figure 3. Pyrrole-2-carboxylic acid (PYC), the specific inhibitor of
PRAC, is not an inhibitor of HyPRE. (A) Percent of L-Pro racemization or
(B) OH-L-Pro epimerization in absence (black bars) or in presence of 1 or
10 mM of PYC (white bars). Reactions were performed at 37uC for
30 min with 10 mg of the corresponding enzymes in NaOAc, pH 6
(PRAC reactions) or TE, pH 8 (HyPRE reactions) and 20 mM of substrate.
doi:10.1371/journal.pone.0000885.g003
Figure 4. Kinetic parameters of Proline racemization and Hydro-
xyproline epimerization. Progress of enzymatic activities was moni-
tored polarimetrically, as described previously [8]. Initial rates were
plotted in function of [S] and kinetic parameters determined with
KaleidagraphH program and Michaelis-Menten equation. Maximum rate
(Vmax) and Michaelis-Menten constant (Km) were obtained at 37uCb y
incubation of 20 mg/ml of each recombinant protein with increasing
concentrations of specific L- (closed circles) or D- (open squares)
substrates. (A) PRAC activity is depicted for C. difficile; (B) HyPRE activity
is depicted for P. aeruginosa. (C) Km and Vmax records of HyPRE reactions
using L- or D- enantiomers were distinctively obtained with recombi-
nant enzymes of B. abortus (BaHyPRE), B. melitensis (BmHyPRE), B. suis
(BsHyPRE) and B. pseudomallei (BpHyPRE). TcPRACA : Km of 29 mM and
Vmax of 5,3610
25 M.sec
21 and TcPRACB : Km of 75 mM and Vmax of
2610
24 M.sec
21.
doi:10.1371/journal.pone.0000885.g004
Figure 5. Alignments of PRAC and HyPRE protein sequences. MCGH and MIII* PRAC motifs are shaded respectively in yellow and green. Catalytic
Cys residues are coloured in red. R1, R2 and R3 indicate critical compulsory differences allowing for the discrimination of PRAC and HyPRE. In the left
margin, sequences corresponding to PRAC are underlined contrasting to HyPRE sequences (plain text). Residues involved in substrate specificity are
shaded in green (PRAC) or blue (HyPRE). The proposed signature for HyPRE (squared) gather an additional block of specific residues downstream
PRAC MIII*. Sequences that do not meet those requirements and thus present unknown functions are in light gray.
doi:10.1371/journal.pone.0000885.g005
PRAC and HyPRE Enzymes
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C88SHyPRE and
C236SHyPRE single mutations induce
radical loss of OH-L/D-Pro epimerization establishing that proton
transfer during HyPRE reaction is indeed dependent on the
presence of the catalytic ‘Cys-Cys’ couple of each subunit
(Figure 6). To validate the weight of the Val60 residue in ligand
accessibility and thus in substrate specificity, the residue was
mutated into glycine (Gly) (
V60GHyPRE) or Phe (
V60FHyPRE),
meeting or not size and stability limits imposed by Val. The
absence of epimerization exhibited by the two mutants revealed
that the Val60 aliphatic residue indeed accounts for OH-Pro ligand
specificity and is consequently essential for HyPRE catalysis.
Conversely, the Phe102 residue on the PRAC catalytic site
environment offers hydrophobic restriction area to the pocket
occupancy restraining the accessibility of OH-Pro.
The space and polarity constraints of PRAC and HyPRE active
sites on protein–ligand interactions are visualized better by
comparing the closer views of the enzyme pockets (Figure 7A
and 7B). Therefore, despite close similarities displayed by PRAC
and HyPRE 3D-structures, the presence of a sizable aromatic
residue or, alternatively, of a small aliphatic or polar amino acid,
unquestionably plays a determinant role on the enzyme/substrate
specificity.
The significance and conservation of PRAC and HyPRE
throughout evolution was investigated by a phylogram using
another PLP-independent enzyme as an uncontroversial outgroup,
i.e. the Haemophilus influenzae diaminopimelate epimerase (DapE).
Figure 7C shows that PRAC and HyPRE cluster in three main
groups. Interestingly, PRAC from C. difficile and C. sticklandii
cluster together with T. cruzi and T. vivax (Trypanosoma vivax
possesses a functional proline racemase. N. Chamond, A. Cosson,
M. Goytia, P. Minoprio, 2007, manuscript to be submitted), the
segregation of the tree branches reflecting their ancient origin. It is
conceivable that the divergence between PRAC and HyPRE is
phylogenetically older than the separation of bacteria, archea and
eukaryotes. Alternatively, possible gene transfer between species
can be envisaged.
DISCUSSION
The discovery of novel microbial genes and metabolic proteins
through genome mining has proven to be a promising approach to
identify potential candidates for drug discovery and therapy
against infections. Despite increased availability of genome data,
the attribution of putative functions to homologous genes
annotations are at times too simple and errors can occur with
the consequence of incorrect scientific dogmas. In this paper we
report that from a selected database assembled from blast searches
using T. cruzi proline racemase (TcPRAC) full-length sequences,
73% of the hits were incorrectly annotated as PRAC or putative
PRAC since most of the proteins do not experimentally display
functional PRAC activity. Consistent with previous data de-
termining critical residues for PRAC catalysis, the present study
reveals that out of 12 ‘PRAC-like’ recombinant proteins from
different pathogens only one (8%), from C. difficile, which is
a significant nosocomial pathogen [19,20], demonstrates truthful
Figure 6. Site-directed mutagenesis of key residues of PaHyPRE
results in loss of enzymatic activity. (A) and (B) Percent of
epimerization of respectively OH-L-Pro and OH-D-Pro exhibited by WT
PaHyPRE or C88S, C236S, V60G and V60F point mutants.
doi:10.1371/journal.pone.0000885.g006
Figure 7. PRAC and HyPRE structural data, pocket constraints and
evolution.(A) Ribbon model of TcPRAC (green, PDB : 1W61) and
PaHyPRE (purple, PDB : 2AZP) subunits revealing the overall similarities
of the 3D-structures. Cys catalytic residues (orange). (B) Close view of
TcPRAC (left panel) and PaHyPRE (right panel) pockets. The two catalytic
Cys residues of PRAC (C130 and C300) and of HyPRE (C88 and C236) are
shown in the reaction center colored in orange sticks. Hydrophobic F102
(green sticks) and aliphatic V60 (blue sticks) residues are depicted
respectively in PRAC and HyPRE reaction centers where Pro and OH-Pro
were modeled. Polarity hindrance imposed by the aromatic PRAC F102
residue and the solvent accessible area for the ligand made possible by
HyPRE V60 residue are shown. (C) Phylogram of PRAC and HyPRE
aligned sequences showing the unrooted tree using H. influenzae DapE
as uncontroversial outgroup. Bacterial and protozoa PRAC cluster
together suggesting that divergence of PRAC and HyPRE took place
before the separation of bacteria and eukaryotes.
doi:10.1371/journal.pone.0000885.g007
PRAC and HyPRE Enzymes
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for human and animal health problems [21–25] have been
incorrectly annotated as PRAC and are in fact HyPRE, i.e. 3
Brucella species, P. aeruginosa and B. pseudomallei. In addition, 33% of
the studied sequences were erroneously annotated though missing
fundamental catalytic residues. To our knowledge, apart from
previous work using purified P. putida HyPRE which associated the
enzyme active site to 14 residues [18], the current work is the first
describing HyPRE full-length genes and may contribute in the
future to better annotation of unknown ORFs.
Based on overall comparisons between PRAC and HyPRE and
despite the evident identities displayed by the peptide sequences,
structural evidences were presented here that allow the discrim-
ination of both enzymatic activities. Considering the results
obtained with PaHyPRE mutants supporting the key role of
Cys88 and Cys236 residues in catalysis and the large overall
structural similarity with TcPRAC, our data supports a reaction
mechanism similar to PRAC where HyPRE equally possesses two
active sites per dimer, each one including two catalytic Cys.
Therefore, Cys88 and Cys236 residues are correctly positioned in
the HyPRE pocket to perform epimerization of C
a OH-Pro chiral
center. However, HyPRE is not inhibited by PYC, the transition
state analogue of Pro. It has previously been shown that
hydrophobic Phe102 (R1) and Phe290 residues present in the
TcPRAC pocket impose polarity restrictions that enable interac-
tions of the enzyme with the C
a Pro ring or the C2 atom of PYC.
Instead, the absence of Phe residues in HyPRE pocket, most
particularly Phe102, and its substitution by an aliphatic Val (or
polar Ser), promotes an ideal environment for accessibility and
stereoinversion of the C
a of OH-Pro. Indeed, mutagenesis of Val60
into Gly or Phe, results in radical loss of PaHyPRE activity,
attributing a significant role to Val60 in the conformation of the
enzyme, the pocket stability and the ligand specificity. It could
though be hypothesized that a single replacement of this central
Val60 residue by an aromatic Phe would be sufficient to affect the
hydrosolubility of the HyPRE pocket environment thus favouring
the accessibility and correct positioning of ‘Pro’ and its further
‘racemization’. Nonetheless, our data shows that this hypothesis is
unlike since PaHyPRE V60F-mutant is unable to perform L-Pro
,.D-Pro conversion. Per se this result is not surprising given that
racemization of Pro by PRAC catalytic Cys is known to be assisted
by neighbor residues of the pocket that are equally present on
HyPRE, such as Leu127, His132 and Asp296, [10], but in addition
by Phe290 which is absent in PaHyPRE sequence. These
neighboring residues may be involved in significant hydrophobic
interactions of the enzyme with its ligand and influence the pKa of
the catalytic Cys residues thus determining the environment
hydrophobicity and as such affecting the stability of the pocket and
resulting catalysis.
On the other hand, PRAC and HyPRE multiple alignments
allowed identification of other important and non dissociated
elements that account for the discrimination of the enzymes, such
as the presence of the aliphatic Cys (or Leu) residue in TcPRAC at
position 270 which is absent and replaced by a polar His residue in
HyPRE (R2) thus favouring its interaction with OH-Pro. Addition-
ally, a block of residues (XLA) downstream of the previously
identified minimal MIII* PRAC signature [7,8] was found to be
HyPRE-specific (R3). The combination of those elements are
fundamental inshaping the binding pocket and thusdetermining the
substratespecificity assupportedbythedetailed structuralanalysis of
TcPRAC and PaHyPRE active sites. It would be interesting to verify
if multiple replacements of discriminating R1, R2 and R3 HyPRE
elements by PRAC specific residues would induce any changes in
substrate specificity. Nevertheless, although HyPRE and PRAC
catalytic sites are structurally very similar, full-sequence disparities
between these two enzymes are still substantial (app. 35%
homology). Consequently, conformational factors (non-R1, non-
R2, non-R3) that contribute to substrate recognition are certainly
more subtle and intricate to distinguish than R1, R2 and R3 whose
identification was exclusively based on sequence ‘(dis)similarities’.
Eventhough, several coexistent mutations might introduce drastic
reductions in kcat and account for a restrained catalytic activity of the
mutant and/or ‘‘asymmetric’’ preferences for a particular substrate
stereoisomer, thus affecting ‘‘racemic principles’’. It is also conceiv-
able that major (extra) distortions in the pocket geometry and charge
delocalization-previously shown to play a role on ligand accessibility
[10]–may occur thus interfering with the analysis.
We report here a clarification of earlier work [13] concerning an
immunomodulatory virulence factor (PrpA) of B. abortus, that
possibly due to its 40% homology with TcPRAC was described as
a PRAC. Surprisingly, PrpA was described as displaying discrete
racemization of L-Pro but as unable of catalyzing the conversion of
D-Pro enantiomer. As such, this data would imply that some
racemases do not follow fundamental racemic principles. The
present data establishes that PrpA from B. abortus, B. melitensis and B.
suisareinfactHyPRE thatcatalyze the interconversion ofOH-L/D-
Pro. These results are significant to prevent anymisinterpretations of
mechanisms linked to pathogenesis induced by Brucella spp.
HyPRE is a PLP-independent enzyme, shown to be essential in
P. putida that, like other Pseudomonas spp, has been found to cause
nosocomial infections with resulting septicemia and septic arthritis
[22,24,26]. Here we identify functional HyPRE from P. aeruginosa
and several other important pathogens such as B. pseudomallei and
Brucella spp agents of melioidosis and brucellosis, respectively
[21,23,25]. These human and animal pathogens affect multiple
systems and result in abcesses, pneumonia and fatal septicemia in
immunosuppressed hosts. Bacterial meningitis can also provoke
collagen degradation and break-down of blood-brain barrier,
which consequently raises bacterial invasiveness and persistence
resulting in brain injuries [27]. Interestingly, OH-L-Pro and L-
Pro, are the major constituents of collagen, the main component of
the extra-cellular matrix, making up 25% of the total body protein
content [15]. Bacteria and viruses, deprived of collagen, have
virulence factors which destroy collagen or interfere with its
production by the secretion of collagenase and/or elastase [28,29].
P. aeruginosa, for instance, induces disruption of blood vessels
through elastase by dissolution of the elastic lamina of arteries and
arterioles, or by degrading major fragments of collagen IV [30]. It
is worth noting that OH-L-Pro upregulates expression of bacterial
genes whose products are involved in vital metabolic pathways,
such as OH-D-Pro oxidase, deaminase and dehydrogenase [31].
Specific membrane transporters for OH-L/D-Pro have been
shown to exist in bacteria to increase the fundamental intracellular
OH-Pro pool [32]. However, mutants lacking HyPRE are unable
to metabolize OH-L-Pro and hence are not viable in OH-L-Pro
containing media as the sole carbon source [31]. This fact alone
confers an essential importance to HyPRE that by converting OH-
L-Pro to OH-D-Pro allows its intracellular utilization by the action
of OH-D-Pro oxidases. We therefore hypothesize that HyPRE, as
PRAC, could serve as a good target for the development of
therapies.
Finally, PRAC enzymes, as other B-cell mitogens, have been
described as involved in evasion mechanisms of parasite and
bacterial species through the induction of non-specific hypergam-
maglobulinemia and by the secretion of pleiotropic cytokines [4,5].
We have shown that similarly to TcPRAC, PRAC from C. difficile
and HyPREs from P. aeruginosa and B. abortus are also strong
lymphocyte mitogens as they increase in vitro lymphoproliferation
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induced proliferation of resting lymphocyte is associated with
a marked increase in amino acid uptake and intracellular enzyme
pathways to meet the demands of increased cellular protein
synthesis [33]. It is relevant that enzymes of Pro biosynthesis, and
not those of Pro degradation, are particularly increased with
lymphocyte activation. However, with sufficient amounts of
exogenous Pro, large increases are observed of pyrroline-5-
carboxylate reductase (PCA reductase), a key enzyme in Pro
synthesis. Isoforms of PCA reductase, sensitive and insensitive to
feedback inhibition by Pro do exist [34]. Interestingly, PCA
reductase from distinct tissues differs according to its sensitivity to
Pro-inhibition. Considering tissue specificity and tropism of
infectious pathogens, it would not be surprising if upon infection
PRAC and HyPRE play important roles in the regulation of the
intracellular and extracellular amino acid pool profiting the
microrganism with precursors and enzymatic pathways of the host.
MATERIALS AND METHODS
Data mining and bioinformatics
TcPRAC sequence (AF195522, NCBI, E.C.5.1.1.4) and PRAC
motif III* were used to blast genome databases. Default settings for
Blast were used. Unrooted trees and alignments were obtained
with ClustalW program.
Bacterial strains and DNA extraction
Purified DNA was obtained from B. anthracis (strain 9131), C.
difficile (strain VPI10463), V. parahaemolyticus (CNRVC 010089), B.
abortus (strain 544), B. melitensis (strain 16M), B. suis (strain 1330)
and B. pseudomallei (strain K96243). DNA was extracted from
bacterial pellets of B. cenocepacia (strain J2315) and P. aeruginosa
(strain PAK) with the DNA tissue culture extraction kit (Qiagen)
Primer design, gene cloning and recombinant
Proteins
Forward and Reverse primers were designed based on TcPRAC
sequence toward specific sequences of the genes of interest (Table
S2, Supplemental files). Bacterial PCR products were purified by
QuickPCR Qiaprep kit (Qiagen) and cloned into BamHI/EcoRI
or BamHI/NcoI sites of pET28b (Novagen/Merck) using Rapid
Ligation Kit (Roche). E. coli DH5a cells were transformed with
empty or ligated plasmids. Plasmids were extracted with the
Qiaprep Spin Miniprep kit (Qiagen) from bacterial pellets from
individual colony cultures and sequenced (Genome Express,
Meylan/France). Sequences, ORFs and the presence of C-
terminal 6x-His Tag were verified. E. coli BL21 (DE3) cells were
transformed with ligated plasmids. Recombinant proteins were
purified as described [7,8].
Enzymatic activity assays
Optimum racemization and epimerization conditions were de-
termined using 20 mM L-Pro or OH-L-Pro in 0.2 M NaOAc or
Tris 20mM/EDTA 1 mM (TE) buffers respectively, as a function
of pH. Percent of racemization or epimerization of serial
concentrations of substrate was calculated by incubating 3–
10 mg of recombinant protein, 20–80 mM substrate in NaOAc
pH 6 or TE, pH 8 (q.s.p. 500 ml) for 30–60 min at 37uC. The
reactions were stopped by incubating at 220uC and optical
rotations measured in a polarimeter 241MC (Perkin Elmer) [8].
Percent inhibition of enzymatic activities was determined in-
cubating 10 mg of recombinant protein in presence or absence of
1–10 mM PYC, 1–25 mM iodoacetamide, or 1–25 mM iodoace-
tate. Control reactions were performed in presence or absence of
PLP. All reagents were purchased from Sigma.
Kinetic assays
Assays were performed at 37uC with 10–160 mM of each
substrate, 20 mg/ml of specific enzymes in optimum reaction
buffer [8]. Briefly, after determination of the linear part of the
curve, velocity in 10–160 mM substrate was measured every 30 s
during 5 min to determine Km and Vmax.
Site directed mutagenesis
Site-directed mutagenesis of PaHyPRE was performed using
a QuikChange XL kit (Stratagene), as described [10], to obtain
the point mutants C88S, C236S, V60F and V60G. Briefly, point
mutations were obtained by PCR using forward and reverse
overlapping mutagenic primers (Figure S3 and Table S2).
Plasmids were purified and point mutations were ascertained by
sequencing. Recombinant proteins were produced from each
point mutant, as described above.
Accession Numbers
The following nucleotide sequences were submitted to Gen-
Bank
TM Data Bank with accession numbers EF495346 (CdPRAC,
C. difficile VPI10463), EF495341 (PaHyPRE, P. aeruginosa PAK),
EF495342 (BmHyPRE, B. melitensis 16M), EF495343 (BsHyPRE,
B. suis 1330), EF495344 (BaHyPRE, B. abortus 544), EF495345
(BpHyPRE, B. pseudomallei K96243).
SUPPORTING INFORMATION
Figure S1 Sequence alignments of Brucella abortus PrpA and
PrpB virulence factors.
Found at: doi:10.1371/journal.pone.0000885.s001 (1.27 MB TIF)
Figure S2 Inhibition of HyPRE reactions with alkylating agents.
Found at: doi:10.1371/journal.pone.0000885.s002 (0.29 MB TIF)
Figure S3 Strategy for PaHyPRE site specific mutagenesis.
Found at: doi:10.1371/journal.pone.0000885.s003 (0.33 MB TIF)
Table S1 Primers used for the production of recombinant
proteins and site-directed mutagenesis.
Found at: doi:10.1371/journal.pone.0000885.s004 (0.42 MB TIF)
Table S2 Mitogenic activity of PRAC and HyPRE enzymes.
Found at: doi:10.1371/journal.pone.0000885.s005 (0.40 MB TIF)
ACKNOWLEDGMENTS
Special thanks to our collaborators P. Arimeter, for availability and useful
tips, A. Blondel, L. Masgrau, Y. Janin and P. Alzari for helpful discussions
and suggestions. We are thankful to the colleagues of the Collection
Nationale de Culture de Microrganismes, Institut Pasteur, C. Fitting for
testing endotoxin from our recombinant protein preparations and P.
Goossens, M.R. Poppof, M. Fournier, M.L. Quilici, V. Balloy and M. Si-
Tahar for providing bacterial strains or bacterial purified DNA. We are
grateful to B. Garin-Bastuji and D. Albert (AFSSA, Maisons-Alfort) and F.
Thibault (CRSSA, La Tronche) for bacterial DNA.
Author Contributions
Conceived and designed the experiments: PM. Performed the experiments:
MG NC AC NC DH. Analyzed the data: PM MG NC AB. Contributed
reagents/materials/analysis tools: AB. Wrote the paper: PM MG NC.
PRAC and HyPRE Enzymes
PLoS ONE | www.plosone.org 7 September 2007 | Issue 9 | e885REFERENCES
1. Stadtman TC, Elliott P (1957) Studies on the enzymic reduction of amino acids.
II. Purification and properties of D-proline reductase and a proline racemase
from Clostridium sticklandii. J Biol Chem 228(2): 983–997.
2. Belasco JG, Albery WJ, Knowles JR (1986) Energetics of proline racemase:
double fractionation experiment, a test for concertedness and for transition-state
dominance. Biochemistry 25(9): 2552–2558.
3. Fisher LM, Albery WJ, Knowles JR (1986) Energetics of proline racemase:
racemization of unlabeled proline in the unsaturated, saturated, and over-
saturated regimes. Biochemistry 25(9): 2529–2537.
4. Reina-San-Martin B, Cosson A, Minoprio P (2000) Lymphocyte polyclonal
activation: a pitfall for vaccine design against infectious agents. Parasitology
today (Personal ed 16(2): 62–67.
5. Reina-San-Martin B, Degrave W, Rougeot C, Cosson A, Chamond N, et al.
(2000) A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline
racemase. Nat Med 6(8): 890–897.
6. Chamond N, Goytia M, Coatnoan N, Barale JC, Cosson A, et al. (2005)
Trypanosoma cruzi proline racemases are involved in parasite differentiation and
infectivity. Mol Microbiol 58(1): 46–60.
7. Chamond N, Coatnoan N, Minoprio P (2002) Immunotherapy of Trypanosoma
cruzi infections. Current drug targets 2(3): 247–254.
8. Chamond N, Gregoire C, Coatnoan N, Rougeot C, Freitas-Junior LH, et al.
(2003) Biochemical characterization of proline racemases from the human
protozoan parasite Trypanosoma cruzi and definition of putative protein signatures.
J Biol Chem 278(18): 15484–15494.
9. Yoshimura T, Esak N (2003) Amino acid racemases: functions and mechanisms.
Journal of bioscience and bioengineering 96(2): 103–109.
10. Buschiazzo A, Goytia M, Schaeffer F, Degrave W, Shepard W, et al. (2006)
Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma
cruzi proline racemase. Proc Natl Acad Sci U S A 103(6): 1705–1710.
11. Adams E (1959) Hydroxyproline metabolism. I. Conversion to alpha-
ketoglutarate by extracts of Pseudomonas. J Biol Chem 234(8): 2073–2084.
12. Radhakrishnan AN, Meister A (1957) Conversion of hydroxyproline to pyrrole-
2-carboxylic acid. J Biol Chem 226(1): 559–571.
13. Spera JM, Ugalde JE, Mucci J, Comerci DJ, Ugalde RA (2006) A B lymphocyte
mitogen is a Brucella abortus virulence factor required for persistent infection. Proc
Natl Acad Sci U S A 103(44): 16514–16519.
14. Adams E (1970) Metabolism of proline and of hydroxyproline. Int Rev Connect
Tissue Res 5: 1–91.
15. Prockop DJ, Kivirikko KI (1995) Collagens: molecular biology, diseases, and
potentials for therapy. Annu Rev Biochem 64: 403–434.
16. Cardinale GJ, Abeles RH (1968) Purification and mechanism of action of proline
racemase. Biochemistry 7(11): 3970–3978.
17. Adams E, Norton IL (1964) Purification and Properties of Inducible
Hydroxyproline 2-Epimerase from Pseudomonas. J Biol Chem 239: 1525–1535.
18. Ramaswamy SG (1984) Hydroxyproline 2-epimerase of Pseudomonas. Subunit
structure and active site studies. J Biol Chem 259(1): 249–254.
19. Bouza E, Munoz P, Alonso R (2005) Clinical manifestations, treatment and
control of infections caused by Clostridium difficile. Clin Microbiol Infect 11 Suppl
4: 57–64.
20. Stoddart B, Wilcox MH (2002) Clostridium difficile. Curr Opin Infect Dis 15(5):
513–518.
21. Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, et al. (2005) From the
discovery of the Malta fever’s agent to the discovery of a marine mammal
reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res
36(3): 313–326.
22. Kipnis E, Sawa T, Wiener-Kronish J (2006) Targeting mechanisms of
Pseudomonas aeruginosa pathogenesis. Med Mal Infect 36(2): 78–91.
23. Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005) Brucellosis. N Engl J Med
352(22): 2325–2336.
24. Sadikot RT, Blackwell TS, Christman JW, Prince AS (2005) Pathogen-host
interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med
171(11): 1209–1223.
25. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ (2006)
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev
Microbiol 4(4): 272–282.
26. Macfarlane L, Oppenheim BA, Lorrigan P (1991) Septicaemia and septic
arthritis due to Pseudomonas putida in a neutropenic patient. The Journal of
infection 23(3): 346–347.
27. Harrington DJ (1996) Bacterial collagenases and collagen-degrading enzymes
and their potential role in human disease. Infection and immunity 64(6):
1885–1891.
28. Miyoshi S, Shinoda S (2000) Microbial metalloproteases and pathogenesis.
Microbes Infect 2(1): 91–98.
29. de Bentzmann S, Polette M, Zahm JM, Hinnrasky J, Kileztky C, et al. (2000)
Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by
altering the actin cytoskeleton and inducing overactivation of epithelial matrix
metalloproteinase-2. Laboratory investigation; a journal of technical methods
and pathology 80(2): 209–219.
30. Bejarano PA, Langeveld JP, Hudson BG, Noelken ME (1989) Degradation of
basement membranes by Pseudomonas aeruginosa elastase. Infection and immunity
57(12): 3783–3787.
31. Gryder RM, Adams E (1969) Inducible degradation of hydroxyproline in
Pseudomonas putida: pathway regulation and hydroxyproline uptake. J Bacteriol
97(1): 292–306.
32. Gryder RM, Adams E (1970) Properties of the inducible hydroxyproline
transport system of Pseudomonas putida. J Bacteriol 101(3): 948–958.
33. Valle D, Blaese RM, Phang JM (1975) Increased sensitivity of lymphocyte
delta1-pyrroline-5-carboxylate reductase to inhibition by proline with trans-
formation. Nature 253(5488): 214–216.
34. Valle D, Downing SJ, Phang JM (1973) Proline inhibition of pyrroline-5-
carboxylate reductase: differences in enzymes obtained from animal and tissue
culture sources. Biochemical and biophysical research communications 54(4):
1418–1424.
PRAC and HyPRE Enzymes
PLoS ONE | www.plosone.org 8 September 2007 | Issue 9 | e885